Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 1.76 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 1.87 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 1.77 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 1.87 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 1.73 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 1.9 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 1.91 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 1.8 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 0.0 | BCD100322A01 | 1.74 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 0.5 | BCD100322A03 | 2 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 1.0 | BCD100322A07 | 1.89 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 2.0 | BCD100322A11 | 1.84 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 4.0 | BCD100322A15 | 1.72 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 8.0 | BCD100322A19 | 1.97 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 12.0 | BCD100322A23 | 1.95 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | C | 24.0 | BCD100322A27 | 2.02 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 1.92 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 1.72 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 1.82 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 1.79 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 1.85 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 1.88 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 1.89 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 0.5 | BCD100322A04 | 1.8 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 1.0 | BCD100322A08 | 1.81 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 2.0 | BCD100322A12 | 1.72 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 4.0 | BCD100322A16 | 1.78 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 8.0 | BCD100322A20 | 1.9 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 12.0 | BCD100322A24 | 2.06 | pmol/sample |
| LMST01010014 | 4β-hydroxy-cholesterol | 25OH-Chol | 24.0 | BCD100322A28 | 1.73 | pmol/sample |